Effect of ethyl chlorophenoxyisobutyrate (CPIB) on plasma lipoprotein lipase activity.
D000284:Administration, Oral; D000818:Animals; D002994:Clofibrate / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006493:Heparin / Q000008:administration & dosage / Q000494:pharmacology; D007275:Injections, Intravenous; D008071:Lipoprotein Lipase / Q000097:blood*; D008297:Male; D051381:Rats
D005230:Fatty Acids, Nonesterified; D006493:Heparin; D008071:Lipoprotein Lipase; D002994:Clofibrate